The skin is the largest organ of the body, which meets the environment most directly. Thus, the skin is vulnerable to various damages, particularly burn injury. Skin wound healing is a serious interaction between cell types, cytokines, mediators, the neurovascular system, and matrix remodeling. Tissue regeneration technology remarkably enhances skin repair via re-epidermalization, epidermal-stromal cell interactions, angiogenesis, and inhabitation of hypertrophic scars and keloids. The success rates of skin healing for burn injuries have significantly increased with the use of various skin substitutes. In this review, we discuss skin replacement with cells, growth factors, scaffolds, or cell-seeded scaffolds for skin tissue reconstruction and also compare the high efficacy and cost-effectiveness of each therapy. We describe the essentials, achievements, and challenges of cell-based therapy in reducing scar formation and improving burn injury treatment.

Articular hyaline cartilage is extensively hydrated, but it is neither innervated nor vascularized, and its low cell density allows only extremely limited self-renewal. Most clinical and research efforts currently focus on the restoration of cartilage damaged in connection with osteoarthritis or trauma. Here, we discuss current clinical approaches for repairing cartilage, as well as research approaches which are currently developing, and those under translation into clinical practice. We also describe potential future directions in this area, including tissue engineering based on scaffolding and/or stem cells as well as a combination of gene and cell therapy. Particular focus is placed on cell-based approaches and the potential of recently characterized chondro-progenitors; progress with induced pluripotent stem cells is also discussed. In this context, we also consider the ability of different types of stem cell to restore hyaline cartilage and the importance of mimicking the environment in vivo during cell expansion and differentiation into mature chondrocytes.

The skin is the layer of flexible outer tissue covering the body and functions as an interface with the environment.^1,2 The main function of the skin is the protection from external factors, for example, against various xenobiotics and pathogens. Water and temperature balances are also regulated based on the processes in the skin. The functions and dysfunctions of the skin, including many pathological conditions, have a significant impact on both the physical health and general wellness of a person.

Osteoarthritis (OA) is a common degenerative joint disease treated mostly symptomatically before approaching its definitive treatment, joint arthroplasty. The rapidly growing prevalence of OA highlights the urgent need for a more efficient treatment strategy and boosts research into the mechanisms of OA incidence and progression. As a multifactorial disease, many aspects have been investigated as contributors to OA onset and progression. Differences in gender appear to play a role in the natural history of the disease, since female sex is known to increase the susceptibility to its development. The aim of the present review is to investigate the cues associated with gender by analyzing various hormonal, anatomical, molecular, and biomechanical parameters, as well as their differences between sexes. Our findings reveal the possible implications of gender in OA onset and progression and provide evidence for gaps in the current state of art, thus suggesting future research directions.

An increasing interest in biomedical applications of terahertz (THz) radiation, featuring the frequencies of 0.1 to 3.0 THz, the free-space wavelengths of $\simeq 3\mathrm{mm}$ to $100\mu \mathrm{m}$, or the quantum energies of $\simeq 0.3$ to 10 meV (see Fig. 1), has been observed during the past few decades,^{1 – 5} driven by rapid progress in THz technology.^6,7 Numerous research papers demonstrate the potential of THz technology in label-free early noninvasive, least-invasive, and intraoperative diagnosis of malignant and benign neoplasms with different nosologies and localizations,^{3,4,8 – 18} sensing of glycated tissues and blood in the context of diabetes diagnosis,^{1,19 – 21} determining the degree of traumatic injuries,^{22 – 25} hydration levels,^{26 – 29} and viability³⁰ of tissues. Along with the diagnostic applications, THz technology holds strong potential in therapeutics,^31,32 for example, in nonthermal regulation in expression of genes associated with cancer and inflammatory diseases.³³ Nevertheless, THz therapy is still at the initial stage of its development.

Matrix-bound nanovesicles (MBVs) are a novel subclass of extracellular vesicles.